Cargando…
Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial
INTRODUCTION: Cardiac adipose tissue is a source of progenitor cells with regenerative capacity. Studies in rodents demonstrated that the intramyocardial delivery of cells derived from this tissue improves cardiac function after myocardial infarction (MI). We developed a new reparative approach for...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724153/ https://www.ncbi.nlm.nih.gov/pubmed/28780562 http://dx.doi.org/10.1136/bmjopen-2017-017187 |
_version_ | 1783285310479663104 |
---|---|
author | Gastelurrutia, Paloma Gálvez-Montón, Carolina Cámara, Maria Luisa Bustamante-Munguira, Juan García-Pavia, Pablo Avanzas, Pablo Alberto San Román, J Pascual-Figal, Domingo de Teresa, Eduardo Crespo-Leiro, Maria G Manito, Nicolás Núñez, Julio Fernández-Avilés, Francisco Caballero, Ángel Teis, Albert Lupón, Josep Brugada, Ramón Martín, Carlos Silva, Jacobo Revilla-Orodea, Ana Cánovas, Sergio J Melero, Jose M Cuenca-Castillo, Jose J Gonzalez-Pinto, Angel Bayes-Genis, Antoni |
author_facet | Gastelurrutia, Paloma Gálvez-Montón, Carolina Cámara, Maria Luisa Bustamante-Munguira, Juan García-Pavia, Pablo Avanzas, Pablo Alberto San Román, J Pascual-Figal, Domingo de Teresa, Eduardo Crespo-Leiro, Maria G Manito, Nicolás Núñez, Julio Fernández-Avilés, Francisco Caballero, Ángel Teis, Albert Lupón, Josep Brugada, Ramón Martín, Carlos Silva, Jacobo Revilla-Orodea, Ana Cánovas, Sergio J Melero, Jose M Cuenca-Castillo, Jose J Gonzalez-Pinto, Angel Bayes-Genis, Antoni |
author_sort | Gastelurrutia, Paloma |
collection | PubMed |
description | INTRODUCTION: Cardiac adipose tissue is a source of progenitor cells with regenerative capacity. Studies in rodents demonstrated that the intramyocardial delivery of cells derived from this tissue improves cardiac function after myocardial infarction (MI). We developed a new reparative approach for damaged myocardium that integrates the regenerative properties of cardiac adipose tissue with tissue engineering. In the adipose graft transposition procedure (AGTP), we dissect a vascularised flap of autologous pericardial adipose tissue and position it over the myocardial scarred area. Following encouraging results in acute and chronic MI porcine models, we performed the clinical trial (NCT01473433, AdiFLAP trial) to evaluate safety in patients with chronic MI undergoing coronary artery bypass graft. The good safety profile and trends in efficacy warranted a larger trial. STUDY DESIGN: The AGTP II trial (NCT02798276) is an investigator initiated, prospective, randomised, controlled, multicentre study to assess the efficacy of the AGTP in 108 patients with non-revascularisable MI. Patients will be assigned to standard clinical practice or the AGTP. The primary endpoint is change in necrotic mass ratio by gadolinium enhancement at 91 and 365 days. Secondary endpoints include improvement in regional contractibility by MRI at 91 and 365 days; changes in functional MRI parameters (left ventricular ejection fraction, left and right ventricular geometric remodelling) at 91 and 365 days; levels of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) at 7, 91 and 365 days; appearance of arrhythmias from 24 hour Holter monitoring at 24 hours, and at 91 and 365 days; all cause death or re-hospitalisation at 365 days; and cardiovascular death or re-hospitalisation at 365 days. ETHICS AND DISSEMINATION: The institutional review board approved the trial which will comply with the Declaration of Helsinki. All patients will provide informed consent. It may offer a novel, effective and technically simple technique for patients with no other therapeutic options. The results will be submitted to indexed medical journals and national and international meetings. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT02798276, pre-results. |
format | Online Article Text |
id | pubmed-5724153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57241532017-12-19 Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial Gastelurrutia, Paloma Gálvez-Montón, Carolina Cámara, Maria Luisa Bustamante-Munguira, Juan García-Pavia, Pablo Avanzas, Pablo Alberto San Román, J Pascual-Figal, Domingo de Teresa, Eduardo Crespo-Leiro, Maria G Manito, Nicolás Núñez, Julio Fernández-Avilés, Francisco Caballero, Ángel Teis, Albert Lupón, Josep Brugada, Ramón Martín, Carlos Silva, Jacobo Revilla-Orodea, Ana Cánovas, Sergio J Melero, Jose M Cuenca-Castillo, Jose J Gonzalez-Pinto, Angel Bayes-Genis, Antoni BMJ Open Cardiovascular Medicine INTRODUCTION: Cardiac adipose tissue is a source of progenitor cells with regenerative capacity. Studies in rodents demonstrated that the intramyocardial delivery of cells derived from this tissue improves cardiac function after myocardial infarction (MI). We developed a new reparative approach for damaged myocardium that integrates the regenerative properties of cardiac adipose tissue with tissue engineering. In the adipose graft transposition procedure (AGTP), we dissect a vascularised flap of autologous pericardial adipose tissue and position it over the myocardial scarred area. Following encouraging results in acute and chronic MI porcine models, we performed the clinical trial (NCT01473433, AdiFLAP trial) to evaluate safety in patients with chronic MI undergoing coronary artery bypass graft. The good safety profile and trends in efficacy warranted a larger trial. STUDY DESIGN: The AGTP II trial (NCT02798276) is an investigator initiated, prospective, randomised, controlled, multicentre study to assess the efficacy of the AGTP in 108 patients with non-revascularisable MI. Patients will be assigned to standard clinical practice or the AGTP. The primary endpoint is change in necrotic mass ratio by gadolinium enhancement at 91 and 365 days. Secondary endpoints include improvement in regional contractibility by MRI at 91 and 365 days; changes in functional MRI parameters (left ventricular ejection fraction, left and right ventricular geometric remodelling) at 91 and 365 days; levels of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) at 7, 91 and 365 days; appearance of arrhythmias from 24 hour Holter monitoring at 24 hours, and at 91 and 365 days; all cause death or re-hospitalisation at 365 days; and cardiovascular death or re-hospitalisation at 365 days. ETHICS AND DISSEMINATION: The institutional review board approved the trial which will comply with the Declaration of Helsinki. All patients will provide informed consent. It may offer a novel, effective and technically simple technique for patients with no other therapeutic options. The results will be submitted to indexed medical journals and national and international meetings. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT02798276, pre-results. BMJ Publishing Group 2017-08-04 /pmc/articles/PMC5724153/ /pubmed/28780562 http://dx.doi.org/10.1136/bmjopen-2017-017187 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Cardiovascular Medicine Gastelurrutia, Paloma Gálvez-Montón, Carolina Cámara, Maria Luisa Bustamante-Munguira, Juan García-Pavia, Pablo Avanzas, Pablo Alberto San Román, J Pascual-Figal, Domingo de Teresa, Eduardo Crespo-Leiro, Maria G Manito, Nicolás Núñez, Julio Fernández-Avilés, Francisco Caballero, Ángel Teis, Albert Lupón, Josep Brugada, Ramón Martín, Carlos Silva, Jacobo Revilla-Orodea, Ana Cánovas, Sergio J Melero, Jose M Cuenca-Castillo, Jose J Gonzalez-Pinto, Angel Bayes-Genis, Antoni Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial |
title | Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial |
title_full | Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial |
title_fullStr | Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial |
title_full_unstemmed | Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial |
title_short | Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial |
title_sort | rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the agtp ii trial |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724153/ https://www.ncbi.nlm.nih.gov/pubmed/28780562 http://dx.doi.org/10.1136/bmjopen-2017-017187 |
work_keys_str_mv | AT gastelurrutiapaloma rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT galvezmontoncarolina rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT camaramarialuisa rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT bustamantemunguirajuan rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT garciapaviapablo rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT avanzaspablo rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT albertosanromanj rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT pascualfigaldomingo rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT deteresaeduardo rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT crespoleiromariag rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT manitonicolas rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT nunezjulio rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT fernandezavilesfrancisco rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT caballeroangel rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT teisalbert rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT luponjosep rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT brugadaramon rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT martincarlos rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT silvajacobo rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT revillaorodeaana rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT canovassergioj rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT melerojosem rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT cuencacastillojosej rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT gonzalezpintoangel rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial AT bayesgenisantoni rationaleanddesignofamulticentreprospectiverandomisedcontrolledclinicaltrialtoevaluatetheefficacyoftheadiposegrafttranspositionprocedureinpatientswithamyocardialscartheagtpiitrial |